ICON Clinical Research, Inc. Enhances Its Italian Operations
Recognising the importance of the Italian pharmaceutical market, ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical industry; today announced the opening of a new office in Milan. This office will support ICON’s expanding clinical research activity in Italy.